These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38979533)

  • 1. Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer.
    Xing Y; Jing R; Tang X; Jiang Z
    Int J Nanomedicine; 2024; 19():6603-6618. PubMed ID: 38979533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-targeting zeolitic imidazole frameworks to overcome platinum-resistant ovarian cancer.
    Xing Y; Jiang Z; Akakuru OU; He Y; Li A; Li J; Wu A
    Colloids Surf B Biointerfaces; 2020 May; 189():110837. PubMed ID: 32058250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic effect and MR molecular imaging of FA-PEG-FePt/DDP nanoliposomes in AMF on ovarian cancer.
    Bian X; Guo T; Chen G; Nie D; Yue M; Zhu Y; Lin M
    Int J Nanomedicine; 2024; 19():5227-5243. PubMed ID: 38855734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming cisplatin resistance in ovarian cancer: A novel approach via mitochondrial targeting peptide Pal-pHK-pKV.
    Yuan Y; Zhang J; Zeng H; Gui A; Yan Y; Zou A; Yang L
    Biochem Biophys Res Commun; 2024 Nov; 734():150616. PubMed ID: 39232456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer.
    Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
    Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anthraquinone derivative KA-4s reduces energy metabolism and enhances the sensitivity of ovarian cancer cells to cisplatin.
    Zhao Y; Li X; Xu S; Yang Y; Chen Q; Li J; Tian W; Zhang Q; Hou H; Li D
    Mol Carcinog; 2024 Nov; 63(11):2090-2102. PubMed ID: 39092774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damage.
    Li Z; Ma X; Yang Y; Wang Y; Zhu W; Deng X; Chen T; Gao C; Zhang Y; Yang W; Xing H; Ye X; Wu A; Zhang X
    Acta Biomater; 2024 Sep; 185():381-395. PubMed ID: 39067643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis.
    Zhou Y; Liu T; Wu Q; Wang H; Sun Y
    Mol Carcinog; 2023 Oct; 62(10):1474-1486. PubMed ID: 37283234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells.
    Li X; Guo Y; Xing Z; Gong T; Yang L; Yang T; Chang B; Wang X; Yu B; Guo R
    Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 39054955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angelica sinensis polysaccharide combined with cisplatin reverses cisplatin resistance of ovarian cancer by inducing ferroptosis via regulating GPX4.
    Guo W; Wang W; Lei F; Zheng R; Zhao X; Gu Y; Yang M; Tong Y; Wang Y
    Biomed Pharmacother; 2024 Jun; 175():116680. PubMed ID: 38703506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY; Li N; Cui YL
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
    Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
    Zhang Y; Zhang P; Zhu T
    Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumiflavin increases the sensitivity of ovarian cancer stem-like cells to cisplatin by interfering with riboflavin.
    Yang R; Wei Z; Wu S
    J Cell Mol Med; 2019 Aug; 23(8):5329-5339. PubMed ID: 31187586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian Cancer
    Zhang X; Wang J; Liu N; Wu W; Li H; Lu W; Guo X
    Mol Pharm; 2023 Nov; 20(11):5440-5453. PubMed ID: 37819754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
    Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.